查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1825912

2025年全球軟便劑市場報告

Stool Softener Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

預計未來幾年，大便軟化劑市場將強勁成長，到2029年將達到23.7億美元，年複合成長率（CAGR）為6.9%。預測期內的成長可歸因於胃腸道疾病病例的增加、醫療保健支出的增加、製藥公司加大行銷力度、許多大便軟化劑從處方箋向非處方藥的轉變以及慢性病的流行。預測期內的主要趨勢包括：醫療診斷和治療的改進、更有效的大便軟化劑配方的開發和核准、配方技術的創新、個人化大便軟化劑產品的開發以及發泡大便軟化劑片的開發。

未來五年6.9%的預測成長率，較我們先前對該市場的預測略有下降0.5%。這一下降主要源自於美國與其他國家之間關稅的影響。貿易摩擦可能導致印度和加拿大研發的多庫酯鈉和滲透性瀉藥價格上漲，從而導致術後恢復延遲和胃腸道藥物成本上升，擾亂美國的胃腸道治療。互惠關稅以及日益加劇的貿易緊張局勢和限制對全球經濟和貿易的負面影響可能會產生更廣泛的影響。

預計未來幾年胃腸道疾病的增加將推動糞便軟化劑市場的成長。胃腸道疾病包括任何影響消化道（從口腔到肛門）的疾病。導致胃腸道疾病盛行率上升的因素包括生活方式的改變，例如不健康的飲食、久坐的生活方式和壓力。糞便軟化劑在緩解胃腸道疾病方面發揮著重要作用，它能夠促進排便、預防便秘並減輕排便壓力。例如，根據加拿大克隆氏症和結腸炎協會的數據，加拿大 IBD 患者數量預計將從 2023 年的 322,600 人（佔人口的 0.8%）大幅增加到 2035 年的 47 萬人（佔人口的 1.1%）。診斷率也預計將從 2023 年的 11,000 例（每 48 分鐘 1 例）上升到 2035 年的 14,000 例（每 38 分鐘 1 例）。因此，胃腸道疾病盛行率的增加是大便軟化劑市場擴張的主要驅動力。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球軟便劑：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 最終用途產業分析
  • 全球大便軟化劑市場：成長率分析
  • 全球大便軟化劑市場表現：規模與成長，2019-2024
  • 全球大便軟化劑市場預測：2024-2029年及2034年規模及成長
  • 全球大便軟化劑：總目標市場（TAM）

第6章 市場細分

  • 全球大便軟化劑市場：按類型、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 液體
  • 軟膠囊
  • 全球大便軟化劑市場：依形式、實際情況和預測，2019-2024 年、2024-2029 年、2034 年
  • 藥品
  • 治療
  • 全球大便軟化劑市場：依給藥方式、實際狀況及預測，2019-2024 年、2024-2029 年、2034 年
  • 口服
  • 直腸
  • 全球大便軟化劑市場：按情況、實際結果和預測，2019-2024 年、2024-2029 年、2034 年
  • 在商店
  • 處方箋
  • 全球大便軟化劑市場：依最終用途、實際及預測，2019-2024 年、2024-2029 年、2034 年
  • 醫院
  • 診所
  • 居家照護
  • 其他最終用途
  • 全球大便軟化劑市場：按液體（按類型）細分，實際及預測，2019-2024 年、2024-2029 年、2034 年
  • 口服溶液
  • 糖漿
  • 降低
  • 全球大便軟化劑市場：依軟膠囊類型細分，實際及預測，2019-2024 年、2024-2029 年、2034 年
  • 標準軟膠囊
  • 增強型或高劑量軟膠囊

第7章 區域和國家分析

  • 全球大便軟化劑市場：按地區、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 全球大便軟化劑市場：依國家/地區、績效及預測（2019-2024 年、2024-2029 年及 2034 年）

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 大便軟化劑市場：競爭格局
  • 大便軟化劑市場：公司簡介
    • F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • Bayer AG Overview, Products and Services, Strategy and Financial Analysis
    • AstraZeneca Plc. Overview, Products and Services, Strategy and Financial Analysis
    • Abbott Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Takeda Pharmaceutical Company Ltd. Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

  • GlaxoSmithKline Plc
  • Boehringer Ingelheim GmbH
  • Solvay SA
  • Teva Pharmaceutical Industries Ltd.
  • Mylan NV
  • Purdue Pharma LP
  • Mallinckrodt Plc
  • Aristo Pharma GmbH
  • Raptakos Brett Co. Ltd.
  • Unipex Group Inc.
  • Chemo Biological
  • Angiolife Healthcare Pvt. Ltd.
  • Iscon Life Sciences
  • Starmed Pvt. Ltd.
  • Phaedrus Ltd.

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章：高潛力市場國家、細分市場與策略

  • 2029年大便軟化劑市場：哪些國家將提供新機會
  • 2029年大便軟化劑市場：細分市場帶來新機會
  • 2029 年大便軟化劑市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章 附錄

簡介目錄
Product Code: r31318u

A stool softener is a laxative designed to ease the passage of stool by increasing intestinal water content, reducing the need for straining. It effectively treats mild constipation and is particularly beneficial for individuals needing to avoid strain post-surgery. Stool softeners are typically used temporarily to alleviate occasional constipation and are accessible without a prescription or as prescribed medication.

Stool softeners come primarily in liquid or softgel capsule forms. Liquid stool softeners are available for oral ingestion or rectal use, facilitating softer and smoother bowel movements. They are administered orally or rectally and are accessible over-the-counter or through prescription, serving diverse users including hospitals, clinics, and home care settings.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The stool softener market research report is one of a series of new reports from The Business Research Company that provides stool softener market statistics, including stool softener industry global market size, regional shares, competitors with a stool softener market share, detailed stool softener market segments, market trends and opportunities, and any further data you may need to thrive in the stool softener industry. This stool softeners market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The stool softener market size has grown strongly in recent years. It will grow from $1.69 billion in 2024 to $1.81 billion in 2025 at a compound annual growth rate (CAGR) of 6.9%. The growth in the historic period can be attributed to the aging population, dietary changes, increased public awareness about digestive health, increased surgical procedures, and lack of physical activity.

The stool softener market size is expected to see strong growth in the next few years. It will grow to $2.37 billion in 2029 at a compound annual growth rate (CAGR) of 6.9%. The growth in the forecast period can be attributed to increasing cases of gastrointestinal conditions, higher healthcare spending, increasing marketing efforts by pharmaceutical companies, the shift of many stool softeners from prescription-only to over-the-counter status, and chronic disease prevalence. Major trends in the forecast period include improvements in medical diagnostics and treatments, the development and approval of more effective stool softener formulations, innovations in formulation technology, the development of personalized stool softener products, and the development of effervescent stool softener tablets.

The forecast of 6.9% growth over the next five years reflects a modest reduction of 0.5% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder U.S. gastrointestinal care by inflating prices of docusate sodium and osmotic laxatives developed in India and Canada, resulting in delayed post-surgical recovery and higher gastroenterology medication costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The anticipated rise in gastrointestinal disorders is set to drive the growth of the stool softener market in the coming years. Gastrointestinal disorders encompass any condition affecting the gastrointestinal tract, spanning from the mouth to the anus. Factors contributing to the increased prevalence of gastrointestinal disorders include lifestyle changes such as unhealthy diet, sedentary habits, and stress. Stool softeners play a crucial role in alleviating gastrointestinal disorders by facilitating easier bowel movements, thereby preventing constipation and reducing strain. For example, according to Crohn's and Colitis Canada, the number of individuals in Canada with IBD is projected to increase significantly from 322,600 in 2023 (0.8% of the population) to 470,000 in 2035 (1.1% of the population). The diagnosis rate is also expected to rise from 11,000 cases in 2023 (1 every 48 minutes) to 14,000 cases in 2035 (1 every 38 minutes). Hence, the growing prevalence of gastrointestinal disorders is a key driver behind the stool softener market's expansion.

Major companies in the stool softener market are focusing on developing innovative products, such as Ayurvedic liquid laxatives, to offer natural and gentle relief options for consumers. An Ayurvedic liquid laxative is a herbal-based formulation designed to ease constipation by promoting smooth bowel movements. It incorporates traditional Ayurvedic ingredients known for their digestive benefits to enhance overall gut health. For example, in December 2023, Lupin Limited, a pharmaceutical company based in India, launched Softovac Liquifibre. This product is a 100% Ayurvedic liquid laxative that blends Isabgol fiber with natural ingredients like Sonamukhi and Harad, providing effective relief from constipation. Clinically validated for safety and efficacy, this product is gentle, non-habit-forming, and safe for daily use, even for diabetics, due to its sugar-free formulation.

In June 2023, Atlantis Consumer Healthcare Inc. acquired several brands, including Colace, Senokot, Betadine, and SlowMag, from Avrio Health L.P. (Avrio) for an undisclosed sum. This acquisition strengthens Atlantis's position as a leader in health and wellness, expanding its ability to improve consumer well-being. Avrio Health L.P. specializes in providing stool softeners.

Major companies operating in the stool softener market are F. Hoffmann-La Roche Ltd., Bayer AG, AstraZeneca Plc., Abbott Laboratories Inc., Takeda Pharmaceutical Company Ltd., GlaxoSmithKline Plc, Boehringer Ingelheim GmbH, Solvay S.A., Teva Pharmaceutical Industries Ltd., Mylan N.V., Purdue Pharma L.P., Mallinckrodt Plc, Aristo Pharma GmbH, Raptakos Brett Co. Ltd., Unipex Group Inc., Chemo Biological, Angiolife Healthcare Pvt. Ltd., Iscon Life Sciences, Starmed Pvt. Ltd., Phaedrus Ltd., Stadmed Pvt. Ltd., Avrio Health L.P., Healwell, Velnex Medicare, Sanify Healthcare Pvt. Ltd.

North America was the largest region in the stool softener market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the stool softener market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the stool softener market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The stool softener market consists of sales of docusate sodium, docusate calcium, liquid gels, and fiber supplements. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Stool Softener Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on stool softener market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for stool softener ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The stool softener market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Liquid; Softgel Capsule
  • 2) By Form: Medicines; Procedures
  • 3) By Mode Of Administration: Oral; Rectal
  • 4) By Availability: Over-The-Counter; Prescription
  • 5) By End Use: Hospitals; Clinics; Home Care; Other End Uses
  • Subsegments:
  • 1) By Liquid: Oral Solutions; Syrups; Drops
  • 2) By Softgel Capsule: Standard Softgel Capsules; Enhanced Or High-Dosage Softgel Capsules
  • Companies Mentioned: F. Hoffmann-La Roche Ltd.; Bayer AG; AstraZeneca Plc.; Abbott Laboratories Inc.; Takeda Pharmaceutical Company Ltd.; GlaxoSmithKline Plc; Boehringer Ingelheim GmbH; Solvay S.A.; Teva Pharmaceutical Industries Ltd.; Mylan N.V.; Purdue Pharma L.P.; Mallinckrodt Plc; Aristo Pharma GmbH; Raptakos Brett Co. Ltd.; Unipex Group Inc.; Chemo Biological; Angiolife Healthcare Pvt. Ltd.; Iscon Life Sciences; Starmed Pvt. Ltd.; Phaedrus Ltd.; Stadmed Pvt. Ltd.; Avrio Health L.P.; Healwell; Velnex Medicare; Sanify Healthcare Pvt. Ltd.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Stool Softener Market Characteristics

3. Stool Softener Market Trends And Strategies

4. Stool Softener Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Stool Softener Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Stool Softener PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Stool Softener Market Growth Rate Analysis
  • 5.4. Global Stool Softener Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Stool Softener Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Stool Softener Total Addressable Market (TAM)

6. Stool Softener Market Segmentation

  • 6.1. Global Stool Softener Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Liquid
  • Softgel Capsule
  • 6.2. Global Stool Softener Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Medicines
  • Procedures
  • 6.3. Global Stool Softener Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Oral
  • Rectal
  • 6.4. Global Stool Softener Market, Segmentation By Availability, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Over-The-Counter
  • Prescription
  • 6.5. Global Stool Softener Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Clinics
  • Home Care
  • Other End Uses
  • 6.6. Global Stool Softener Market, Sub-Segmentation Of Liquid, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Oral Solutions
  • Syrups
  • Drops
  • 6.7. Global Stool Softener Market, Sub-Segmentation Of Softgel Capsule, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Standard Softgel Capsules
  • Enhanced Or High-Dosage Softgel Capsules

7. Stool Softener Market Regional And Country Analysis

  • 7.1. Global Stool Softener Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Stool Softener Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Stool Softener Market

  • 8.1. Asia-Pacific Stool Softener Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Stool Softener Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Stool Softener Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Stool Softener Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Stool Softener Market

  • 9.1. China Stool Softener Market Overview
  • 9.2. China Stool Softener Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Stool Softener Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Stool Softener Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Stool Softener Market

  • 10.1. India Stool Softener Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Stool Softener Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Stool Softener Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Stool Softener Market

  • 11.1. Japan Stool Softener Market Overview
  • 11.2. Japan Stool Softener Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Stool Softener Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Stool Softener Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Stool Softener Market

  • 12.1. Australia Stool Softener Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Stool Softener Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Stool Softener Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Stool Softener Market

  • 13.1. Indonesia Stool Softener Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Stool Softener Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Stool Softener Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Stool Softener Market

  • 14.1. South Korea Stool Softener Market Overview
  • 14.2. South Korea Stool Softener Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Stool Softener Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Stool Softener Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Stool Softener Market

  • 15.1. Western Europe Stool Softener Market Overview
  • 15.2. Western Europe Stool Softener Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Stool Softener Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Stool Softener Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Stool Softener Market

  • 16.1. UK Stool Softener Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Stool Softener Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Stool Softener Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Stool Softener Market

  • 17.1. Germany Stool Softener Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Stool Softener Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Stool Softener Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Stool Softener Market

  • 18.1. France Stool Softener Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Stool Softener Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Stool Softener Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Stool Softener Market

  • 19.1. Italy Stool Softener Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Stool Softener Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Stool Softener Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Stool Softener Market

  • 20.1. Spain Stool Softener Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Stool Softener Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Stool Softener Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Stool Softener Market

  • 21.1. Eastern Europe Stool Softener Market Overview
  • 21.2. Eastern Europe Stool Softener Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Stool Softener Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Stool Softener Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Stool Softener Market

  • 22.1. Russia Stool Softener Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Stool Softener Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Stool Softener Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Stool Softener Market

  • 23.1. North America Stool Softener Market Overview
  • 23.2. North America Stool Softener Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Stool Softener Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Stool Softener Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Stool Softener Market

  • 24.1. USA Stool Softener Market Overview
  • 24.2. USA Stool Softener Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Stool Softener Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Stool Softener Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Stool Softener Market

  • 25.1. Canada Stool Softener Market Overview
  • 25.2. Canada Stool Softener Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Stool Softener Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Stool Softener Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Stool Softener Market

  • 26.1. South America Stool Softener Market Overview
  • 26.2. South America Stool Softener Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Stool Softener Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Stool Softener Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Stool Softener Market

  • 27.1. Brazil Stool Softener Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Stool Softener Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Stool Softener Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Stool Softener Market

  • 28.1. Middle East Stool Softener Market Overview
  • 28.2. Middle East Stool Softener Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Stool Softener Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Stool Softener Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Stool Softener Market

  • 29.1. Africa Stool Softener Market Overview
  • 29.2. Africa Stool Softener Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Stool Softener Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Stool Softener Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Stool Softener Market Competitive Landscape And Company Profiles

  • 30.1. Stool Softener Market Competitive Landscape
  • 30.2. Stool Softener Market Company Profiles
    • 30.2.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. AstraZeneca Plc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Abbott Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Takeda Pharmaceutical Company Ltd. Overview, Products and Services, Strategy and Financial Analysis

31. Stool Softener Market Other Major And Innovative Companies

  • 31.1. GlaxoSmithKline Plc
  • 31.2. Boehringer Ingelheim GmbH
  • 31.3. Solvay S.A.
  • 31.4. Teva Pharmaceutical Industries Ltd.
  • 31.5. Mylan N.V.
  • 31.6. Purdue Pharma L.P.
  • 31.7. Mallinckrodt Plc
  • 31.8. Aristo Pharma GmbH
  • 31.9. Raptakos Brett Co. Ltd.
  • 31.10. Unipex Group Inc.
  • 31.11. Chemo Biological
  • 31.12. Angiolife Healthcare Pvt. Ltd.
  • 31.13. Iscon Life Sciences
  • 31.14. Starmed Pvt. Ltd.
  • 31.15. Phaedrus Ltd.

32. Global Stool Softener Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Stool Softener Market

34. Recent Developments In The Stool Softener Market

35. Stool Softener Market High Potential Countries, Segments and Strategies

  • 35.1 Stool Softener Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Stool Softener Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Stool Softener Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer